FGC
JAZZ icon

Financial Gravity Companies’s Jazz Pharmaceuticals JAZZ Stock Holding History

Financial Gravity Companies’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$143K Buy
+1,117
New +$166K 0.13% 168
2018
Q1 		$192K Buy
1,271
+705
+125% +$103K 0.2% 100
2017
Q4 		$82K Buy
+566
New +$78.5K 0.09% 208

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Financial Gravity Companies's JAZZ Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Jazz Pharmaceuticals (JAZZ) in Q4 2018: 1,117 shares worth $143K. The stake represents 0.13% of the portfolio and ranks #168 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in JAZZ as recently as Q1 2018.

Financial Gravity Companies first reported a position in JAZZ in Q4 2017 and has held it in 3 quarters since. The position peaked at $192K in Q1 2018. 417 funds tracked by Wall St. Rank hold JAZZ as of Q4 2018.

  • Financial Gravity Companies held 1,117 shares of Jazz Pharmaceuticals worth $143K as of Q4 2018.
  • Jazz Pharmaceuticals was a new Financial Gravity Companies position in Q4 2018.
  • Jazz Pharmaceuticals made up 0.13% of Financial Gravity Companies's portfolio in Q4 2018, its #168 holding.
  • Financial Gravity Companies first reported a position in Jazz Pharmaceuticals in Q4 2017 and has held it in 3 quarters since.
  • Financial Gravity Companies's Jazz Pharmaceuticals position peaked at $192K in Q1 2018.
  • 417 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.